Trial NCT00673920

View at ClinicalTrials.gov 
Org. Study IDs: ACT4394g
Secondary IDs: WA20496

Last trial update was posted on 2020-12-04

MeSH Interventions

Methotrexate Ocrelizumab

MeSH Conditions

Arthritis Arthritis, Rheumatoid

Other Conditions

Rheumatoid Arthritis

Stopping Reasons

Based on analysis of results and consideration of available treatments, the overall benefit to risk profile of ocrelizumab was not favorable in RA.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID